Simone de Vries Lentsch

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Genome Wide Identification

Binding Protein

Patient Reported

Top Venues

European journal of neurology

Cephalalgia : an international journal of headache

Journal of neurology, neurosurgery, and psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Simone de Vries Lentsch, Matthijs J L Perenboom, Johannes A Carpay, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Visual hypersensitivity in patients treated with anti-calcitonin gene-related peptide (receptor) monoclonal antibodies. Headache (2023)
Rein F van Welie, Floor C van Welie, Simone de Vries Lentsch, Albert Dahan, Monique van Velzen, Gisela M Terwindt
Characterizing opioid use in a Dutch cohort with migraine. Cephalalgia : an international journal of headache 43 (5) (2023)
Iris Elsa Verhagen, Simone de Vries Lentsch, Britt W H van der Arend, Saskia le Cessie, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Both perimenstrual and non-perimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies. European journal of neurology (2023)
Simone de Vries Lentsch, Britt W H van der Arend, Irene de Boer, Erik W van Zwet, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine. European journal of neurology (2023)
Rein F van Welie, Floor C van Welie, Simone de Vries Lentsch, Albert Dahan, Monique van Velzen, Gisela M Terwindt
Characterizing opioid use in a Dutch cohort with migraine. Cephalalgia : an international journal of headache 43 (5) (2023)
Simone de Vries Lentsch, Britt W H van der Arend, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study. Neurology 99 (17) (2022)
Simone de Vries Lentsch, Linda Al-Hassany, Michel Dominique Ferrari, Gisela Marie Terwindt, Antoinette MaassenVanDenBrink
CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab. Journal of neurology, neurosurgery, and psychiatry 93 (8) (2022)
Simone de Vries Lentsch, Iris E Verhagen, Thomas C van den Hoek, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Treatment with the monoclonal calcitonin gene-related peptide receptor antibody erenumab: A real-life study. European journal of neurology 28 (12) (2021)